Uncoupling protein 1 (UCP1) plays an important role in increasing energy expenditure and is considered as a new target for preventing obesity and metabolic complications. Quercetin elicits protective effects against obesity-induced peripheral/central inflammation and metabolic dysregulations. [1] [2] [3] [4] Our previous study , which are responsible for cardiovascular effects such as increased heart rate and blood pressure. Interestingly, similar to β2-adrenegic receptor, stimulation of β3-adrenergic receptor increases the generation of cyclic AMP and the activation of protein kinase A; however, it is likely that β3-adrenergic receptor stimulation suppresses β2-adrenergic receptor over-activation in the myocardium. 7, 8 Hence, it is tempting to speculate that quercetin may enhance UCP1 in the adipose tissues through norepinephrine-mediated β-adrenergic receptor activation without adverse cardiovascular effects. Further studies are needed to determine how quercetin enhances plasma norepinephrine and β3-adrenergic receptor mRNA in the adipose tissues, as well as the stress issue.
